Bavarian Nordic Signs Four-Year UK Contract for MVA-BN Vaccine Supply

Bavarian Nordic Signs Four-Year UK Contract for MVA-BN Vaccine Supply

Audio narration · Coming soon

Bavarian Nordic has secured a four-year contract with the UK Government to supply its MVA-BN vaccine. This vaccine is used for the prevention of mpox and smallpox. The agreement ensures continued availability of the vaccine in the UK over the next several years.

Why this matters

PRISM scored this story 55/100 for interest.

Originally published by gnews